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Abstract
Background: Technological tools such as Web-based social networks, telemedicine, apps, or wearable devices are becoming
more widespread in health care like elsewhere. Although patients are the main users, for example, to monitor symptoms and
clinical parameters or to communicate with the doctor, their perspective is seldom analyzed, and to the best of our knowledge,
no one has focused on the patients’ health care advocacy associations’ point of view.
Objective: The objective of this study was to assess patients’ health care advocacy associations’ opinions about the use,
usefulness, obstacles, negative aspects, and impact of health apps and wearable devices through a Web-based survey.
Methods: We conducted a Web-based survey through SurveyMonkey over nearly 3 months. Participants were contacted via
an email explaining the aims of the survey and providing a link to complete the Web-based questionnaire. All the 20 items were
mandatory, and the anonymized data were collected automatically into a database. Only fully completed questionnaires were
considered for analysis.
Results: We contacted 1998 patients’ health care advocacy associations; a total of 258 questionnaires were received back
(response rate 12.91%), and 227 of the received questionnaires were fully completed (completion rate 88.0%). Informative apps,
hospital apps for viewing medical reports or booking visits, and those for monitoring physical activity are the most used. They
are considered especially useful to improve patients’ engagement and compliance with treatment. Wearable devices to check
physical activity and glycemia are the most widespread considering, again, their benefits in increasing patients’ involvement and
treatment compliance. For health apps and wearable devices, the main obstacles to their use are personal and technical reasons;
the risk of overmedicalization is considered the most negative aspect of their constant use, while privacy and confidentiality of
data are not rated a limitation. No statistical difference was found on stratifying the answers by responders’ technological level
(P=.30), age (P=.10), and the composition of the association’s advisory board (P=.15).
Conclusions: According to responders, health apps and wearable devices are sufficiently known and used and are considered
potential supports for greater involvement in health management. However, there are still obstacles to their adoption, and the
developers need to work to make them more accessible and more useful. The involvement of patients and their associations in
planning services and products based on these technologies (as well as others) would be desirable to overcome these barriers and
boost awareness about privacy and the confidentiality of data.
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Introduction
New technologies, connectivity, and availability of the internet
have boosted the development of mobile apps and wearable
devices in the last decade. Those for health and care focus
mainly on the management of chronic conditions such as
diabetes [1], cardiovascular diseases [2], and specific
populations or conditions [3,4]. Moreover, these devices have
gained ground in health self-monitoring and preventive medicine
[5]. Italy is the second most frequent worldwide user of new
technology, particularly wearables, after the United States and
before Germany and France [6].
Electronic health (eHealth) and medical devices such as apps
and wearable devices are becoming more and more important
in health debate. In the past year alone, health apps have grown
by nearly 78,000 units, reaching a total of 325,000 registered
[7]. Despite their spread, however, the use of these new
technologies arouses discussions about the collection and sharing
of data, focused on their protection, privacy, accuracy, and
reliability [8,9].
A recent study about the most downloaded “mobile health
(mHealth) apps” found that only 30.5% had a privacy policy.
However, many of these documents used technical language
not accessible to most lay people or they did not focus enough
on the app itself [10,11]. Moreover, health data are often stored
in the “cloud” so we cannot know where it is exactly, making
it not completely safe [12].
There is still debate in the literature on the use and efficacy of
apps and wearable devices to help patients collect and access
their clinical data [13]. To date, patients’ engagement is
considered an important clinical outcome, and these tools could
make them more responsible for treatment management,
monitoring symptoms, identifying risk factors, and how best to
prevent other diseases, for example, by changing their lifestyle
[14]. Health apps or wearable devices could be suitable above
all for chronic diseases. Evidence of this comes from a
systematic review based on randomized controlled trials, where
Yuan et al reported that the use of mobile apps by diabetic adults
lowered glycemia more than standard care alone [15].
Several surveys on consumer perspective [16,17], use of
mHealth app [18], and wearable devices [19] have been
conducted regarding the use of technological tools in health
care; however, to the best of our knowledge, none has been
related to patients’ health care advocacy associations. These
associations, in Italy, like in other industrialized countries, are
a growing reference point in the public health debate and
innovation, influencing research and the political agenda [20].
The associations are spokespersons for a multiplicity of opinions
and collecting their points of view is the best way to actually
engage consumers and patients better. We conducted an
observational study through a Web-based survey to analyze the
representatives of health care advocacy associations’ point of
view.
Methods
Methodology
The Web-based survey was close, voluntary, and took only a
few minutes to complete. No incentive was given. The
SurveyMonkey Web-based survey service [21] was used to
design the questionnaire, manage the survey, and collect data.
The Web questionnaire was 5 pages long, and all data were
anonymized and protected by Norton and TRUSTe.
An email was sent to 1998 contacts, describing the survey and
including a link inviting them to complete the questionnaire.
Reminder emails were sent after 3, 5, and 7 weeks. The
questionnaire was organized in a series of linked pages
(multiple-item screens) with electronic instructions to facilitate
the flow. A progress indicator was permanently visible, and
compilers could enter a personal comment for each question.
The questions were in bold type, and the answers had optional
buttons.
According to the “Checklist for Reporting Results of Internet
E-Surveys” (CHERRIES), all the questions, except the last one,
were mandatory to obtain more solid data on the endpoints of
the survey. To guarantee the possibility of answering, most
questions provided a nonresponse option, that is, “I don’t know.”
Again, based on the CHERRIES checklist, we analyzed only
completed questionnaires, excluding questionnaires that had
missing data due to the responder stopping early and leaving
the website.
If all answers were not completed, it was not possible to continue
and confirm the questionnaire. A “back button” was provided
to change answers before submitting them, but thereafter, no
further changes were allowed. The answers were collected
automatically in the SurveyMonkey database. Overall, 6
questionnaires were filled manually in the database by the
coordinator center to clean up any technical problems of the
responders. Of note, under Italian law, ethical approval was not
required for this kind of survey.
Development of the Questionnaire
We conducted a literature review in PubMed using the following
keywords: “digital technologies,” “survey,” “questionnaire,”
“eHealth,” “mHealth,” “digital health,” “digital innovation,”
and “development.” We retrieved a number of surveys about
“digital innovation” involving citizens but none involved
patients’ health care advocacy associations. Based on the
material collected, we drafted 20 items about the use, usefulness,
obstacles, negative aspects, and impact related to eHealth
technologies, focusing on health apps and wearable devices.
In addition, we recorded the characteristics of the patients’ health
care advocacy associations contacted (year of foundation,
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setting, geographic distribution, and current composition of the
advisory board) and of responders (sex, age, education, personal
use of health apps, or wearable devices) to have a complete
framework of the sample (see Multimedia Appendix 1). In this
regard, some previous studies showed that age and individual
technological level influenced a person’s interest in the adoption
of health apps also in clinical situations [22].
We pretested the questionnaire with the collaboration of 16
representatives of patients’ health care advocacy associations
to assess its readability, clarity, and completeness and to collect
suggestions. Seven representatives answered, and a general
positive consensus was gathered; hence, no major changes were
required.
Recruitment
We started from a database of patients’ health care advocacy
associations available at the “Laboratory for Medical Research
and Consumer Involvement” (n=2087); duplicate and wrong
email addresses were removed (n=98). This database, developed
in 2004, includes contacts of members of the board of
associations—no single member—who had participated in
previous research projects, training courses, and initiatives.
We sent one email invitation to each association, usually to the
president of the association or a member of the board. The
questionnaire asked for his or her personal opinion (see
questions 7-10 and 14 in the Multimedia Appendix 1) and to
report the common belief of the members represented (see
questions 11-13 in the Multimedia Appendix 1).
The survey was announced through Web on the Mario Negri
Institute websites and 2 patients’ health care association
websites; 9 health care associations requested to participate by
contacting the coordinator center directly. Overall, 1998
patients’ health care advocacy associations were reached via
emails. A unique site visitor was permitted by checking the
internet protocol address of responder. Results were presented
according to CHERRIES” [23] and a similar guideline
formulated by Bennett et al [24].
Statistical Analysis
Descriptive analyses were conducted using SAS version 9.4
(SAS Institute Inc) to cross variables according to several
criteria. On the basis of the previous studies suggestions, we
analyzed the pattern of answers by responders’ age and their
technological level. In addition, we considered the composition
of the advisory board of the patients’ health care advocacy
associations as a possible confounding factor. A statistical test
(P value) was expected only for results that gave significant
patterns using a predetermined alpha level of .05.
Results
The survey was open from March 23 to June 8, 2017. A total
of 258 answers were collected, giving a response rate of 12.91%
(258/1998). We analyzed 227 completed questionnaires, as 31
responders dropped out before completing the questionnaire,
giving a completion rate of 88.0% (227/258).
Tables 1 and 2 summarize the main characteristics of the
patients’ health care advocacy associations and responders,
respectively. Out of 227 responders, 121 (53.3%) worked
locally, while 43 (18.9%) and 63 (27.8%) worked on the regional
and national levels, respectively. Most associations were based
in the north of Italy. The advisory board comprised all or most
of the patients or relatives for 58.6% (133/227) answers;
furthermore, 18.1% (41/227) responders stated that there were
no patients or relatives on their board. Respondents were aged
25-88 (mean age 56, SD 12) years; females and males were
fairly represented, and 46.3% (105/227) respondents reported
an appreciable level of technology, using at least one health app
or wearable device, or both.
According to the 227 participants, Web-based social networks
were used for health communication, promotion, or grouping
patients with a specific disease, and telemedicine had a great
impact on health care out of all technological innovations, with
183 (80.6%) responders and 178 (78.4%) of preferences,
respectively; these were followed by wearable devices, such as
smart-watches or wristbands, and health apps, with 148 (65.2%)
and 146 (64.3%) responders, respectively. However, they
foresaw that in the next 3 years, the impact would increase more
for health apps, wearable devices, and telemedicine services
than for Web-based social networks (Table 3).
Among health apps, those providing health and disease
information, hospital apps for services such as viewing medical
reports or booking visits, and those for tracking fitness or
physical activity were the most used by members of health care
advocacy associations, with 149 (65.6%), 118 (52.0%), and 116
(51.1%) of 227 participants, respectively. Apps to improve
treatment and medication compliance, health or condition
trackers, and diet or nutrition apps followed with 106 (46.7%),
96 (42.2%), and 80 (35.2%) of 227 responders, respectively.
Symptom-checker apps for self-diagnosis were the least used,
with 22.0% (50/227) positive answers. Wearable devices
monitoring physical activity and glycemia were the most
widespread among 227 respondents—110 (48.5%) and 108
(47.6%), respectively—followed by those monitoring heart rate
and blood pressure, weight, and sleep tracking, with 106
(46.7%), 88 (38.8%), and 64 (28.2%) respondents, respectively.
From the point of view of patients’ health care advocacy
associations’ representatives, health apps and wearable devices
are not only useful to improve patients’ engagement in their
own health and treatment compliance but also to help them
understand their health status and conditions, enhancing the
communication between patients and physicians, and reducing
health care costs (Table 4).
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Table 1. Characteristics of patients’ health care advocacy associations (N=227).
Associations, n (%)Characteristics
Year of foundation
119 (52.4)1940-1999
108 (47.6)2000-2016
Types
38 (16.7)Oncology
34 (15.0)Diabetes
28 (12.3)Rare diseases
19 (8.4)Neurology
15 (6.6)Cardiovascular
12 (5.3)Disability
13 (5.7)Breast cancer
7 (3.1)Pediatric
5 (2.2)AIDS
4 (1.8)Brain-injured
2 (0.9)Autism
1 (0.4)Asthma
49 (21.6)Other
Geographic distribution
126 (55.5)North
50 (22.0)Center
51 (22.5)South-Islands
Weblink
203 (89.4)Website
186 (81.9)Facebook account
80 (35.2)Twitter account
74 (32.6)YouTube channel
43 (18.9)Blog
Advisory board
78 (34.4)All members are patients or their relatives
55 (24.2)Most members are patients
27 (11.9)Patients’ representatives are nearly half
26 (11.5)Patients’ representatives are a minority
41 (18.1)There are no patients’ representatives
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Table 2. Characteristics of responders (N=227).
Responders, n (%)Characteristics
Sex
100 (44.1)Males
127 (56.0)Females
Age in years
67 (29.5)≤50
106 (46.7)51-65
54 (23.8)>65
Education level
1 (0.4)Elementary school
10 (4.4)Secondary school
93 (41.0)High school
121 (53.3)Degree or superior
2 (0.9)Other
Personal use of health app or wearable
38 (16.7)Both
50 (22.0)Only health app
17 (7.5)Only wearable
122 (53.7)None
Table 3. Impact of technological tools on medical care and health (N=227).
Responders, n (%)Technological tool
Future impactCurrent impact
NoYesNoYes
35 (15.4)192 (84.6)81 (35.7)146 (64.3)Health app
44 (19.4)183 (80.6)79 (34.8)148 (65.2)Wearable
16 (7.1)211 (93.0)49 (21.6)178 (78.4)Telemedicine
30 (13.2)197 (86.8)44 (19.4)183 (80.6)Social network
Table 4. Utility of health apps and wearables in health care (N=227).
Responders, n (%)Utility
Negative or no effectPositive effect
23 (10.1)204 (89.9)Empowerment in own health
60 (26.4)167 (73.6)Improve doctor-patient communication
48 (21.1)179 (78.9)Understand own health condition
100 (44.1)127 (55.9)Reduce public health costs
41 (18.1)186 (81.9)Improve compliance
Responders reported that the main obstacles to the adoption of
health apps and wearable devices among members of their health
care advocacy associations were personal motivations, such as
concern about not being able to use them, or technical reasons,
including owning an unsuitable smartphone, followed by the
lack of evidence of their usefulness, accuracy, and reliability.
Conversely, the lack of confidence in data protection and
confidentiality seemed to restrict their use for only 31.3%
(71/227) responders. It was interesting to highlight that about
a quarter of responders had no clear opinion about the privacy
and accuracy of data collected through apps and wearable
devices (Table 5).
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Table 5. Obstacles related to the use of health apps and wearables (N=227).
I don’t know, n (%)No, n (%)Yes, n (%)Obstacles
31 (13.7)52 (22.9)144 (63.4)Technical barrier
35 (15.4)48 (21.2)144 (63.4)Personal opinion
65 (28.6)89 (39.2)73 (32.2)Low trust in recorded data utility
57 (25.1)100 (44.1)70 (30.8)Low trust in data reservation and privacy
76 (33.5)80 (35.2)71 (31.3)Low trust in recorded data reliability and quality
78 (34.4)59 (26.0)90 (39.6)Low example of their utility in public health
Table 6. Negative aspects of constant adoption of health apps and wearable devices (N=227).
No, n (%)Yes, n (%)Negative aspects
79 (34.8)148 (65.2)Become dependent
157 (69.2)70 (30.8)No privacy
78 (34.4)149 (65.6)Excessive control of own health
67 (29.5)160 (70.5)Overmedicalization
126 (55.5)101 (44.5)Weaken doctor-patient communication
Among negative aspects or risks about the use of health apps
and wearable devices, respondents considered first
overmedicalization (ie, the overuse of drugs, supplements, and
medical devices or scheduling medical examinations even if
they are not really needed), followed by the risk of becoming
dependent on technology, or weakening patient-doctor
communication (Table 6). The lack of confidence in the
protection and confidentiality of data was considered a negative
aspect only by 30.8% (70/227) responders in agreement with
the answers related to the obstacles reported in Table 5.
When we asked about the kind of health apps on which
developers should focus in future to improve medical care and
health, respondents put first those improving and disseminating
health services and tools, with out of 227, 186 (81.9%)
preferences, followed by those boosting compliance (175,
77.1%) and those monitoring vital signs (156, 68.7%), diet and
nutrition (147, 64.8%), and physical activity (137, 60.4%). Of
the 227 respondents, about two-third (154, 67.8%) asked to
focus the efforts on informative health apps, while only 101
(44.5%) wanted more attention to symptom-checker apps. For
wearable devices, the respondents stated that more attention
could be paid to heart rate and blood pressure monitoring (167,
73.4%), glycemia (165, 72.7%), weight monitoring (139,
61.2%), and fitness trackers (136/227, 60.0%); less interest was
shown in sleep trackers (112, 49.3%).
Data about the use, usefulness for health care, obstacles, and
negative aspects of health apps and wearable devices were
stratified by the respondents’ age (≥58 years), technological
level (users of one health app or one wearable device at least
compared to not users), and the composition of the association’s
advisory board (all or most are patients compared to few or no
patients). There were no statistically significant associations,
although there was a slight influence of the technological level
of responders. High technological level responders reported a
greater positive impact of all technological tools (health apps,
wearable devices, telemedicine, and Web-based social networks)
on health and health care, now and in the future than the lower
technological level responders. In addition, attitudes were
different toward the usefulness of health apps and wearable
devices. According to high technological responders, patients’
engagement and compliance with treatment related to these
tools were most important. In addition, higher technological
level responders considered the risk of becoming dependent
and excessive control of one’s own health less important than
the less technological ones.
Discussion
This study offers an exclusive view of patients’ health care
advocacy associations’ opinions about eHealth technological
tools that have not yet been well explored. The results suggest
that the most commonly used health apps appear to be
informative apps, apps providing access to hospital services,
and fitness or physical activity tracking apps, while the favorite
wearable devices are those for fitness, blood glucose, and heart
rate monitoring. Our findings are different from those reported
in a recent study based on citizens where fitness, diet or
nutrition, and symptom navigator apps were at the top of the
rankings with 59%, 52%, and 36% of use, respectively [17]. In
addition, our results differ from those reported in a recent study
focused on consumer’s perceived attitudes about wearable
devices in health monitoring, in which exercise coaching (61%)
and location tracking (59%) came first [19].
Despite this, our results are similar to those from a study
conducted on patients and confirm how both health apps and
wearable devices can be used for patient engagement. In fact,
a recent survey found that the main reasons for their adoption
were chronic disease management (81%), support for medical
adherence (66%), and fitness tracking (46%) [13].
Respondents are optimistic about the future of health apps and
wearable devices. They suggest that in the near future,
developers should focus on apps providing more services,
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increasing drug and therapy compliance, and monitoring vital
signs.
The gaps between current opinion and needs may be explained
considering that today’s responders are concerned about the
reliability of the data collected by health apps and wearable
devices but are confident that in the future, more evidence will
be provided to support their use and efficacy in collecting data
for diseases monitoring and management. On the other hand,
our survey shows that the lack of evidence of reliability and
accuracy of health apps and wearable devices, along with
difficulty in adopting them, are the main obstacles to their use.
About the accuracy—but also the effectiveness—of these tools,
researchers need to raise the overall quality of interventional
trials conducted on patients, focusing on mobile apps and
wearable devices. These trials are still limited due to the short
follow-up, low recruitment rate, and high proportion of
withdrawals before the scheduled time. It is, therefore, hard to
see whether they might become valuable for helping patients
with their own health [25].
Other studies raised the question of discontinuing the use of
health apps and wearable devices when the real setting is not
taken into consideration. For example, a recent study showed
that the majority of users increased their physical activity after
purchasing a wearable device, but nearly one-third stopped
tracking after just 6 months [26]. Another study found that 55%
of the 325,000 health apps available in the app stores are
downloaded <5000 times and only 2% of all health apps count
>500,000 monthly active users [7]. Fuller involvement of
patients and their associations to identify specific needs could
probably narrow this gap and make wearable devices and health
apps more appealing and useful for engagement [27].
The lack of confidence in data protection and confidentiality
seemed not to limit the use of health apps and wearable devices
and did not appear to be one of the main negative aspects. This
is very important because the adoption of apps and wearable
devices in health care might give rise to challenges about
security, data protection, and data reuse [8,9]. For example, a
study on 79 apps certified as clinically safe and trustworthy by
the “UK-National Health Service Health Apps Library” revealed
that 89% of them transmitted information to Web-based services,
and none encrypted personal information stored locally.
Two-thirds of the apps sent personal information over the
internet without encryption and 20% did not have a specific
privacy policy [28]. However, it is interesting that about a
quarter of our responders knew little about the question of data
privacy and confidentiality; a possible explanation is that
patients’ representatives themselves do not know enough,
necessitating more awareness and information. An alternative
reason is that participants do not care much about these topics
and are willing to exchange part of their data for a potential
health care gain.
This survey has several limitations. First, respondents are
representatives of health care advocacy associations and
answered reporting their point of view and the patients’
perspective. Second, as Italy has no central database of
consumers’ and patients’ associations, we contacted a limited
number of associations; hence, this sample may not be
representative of all Italian situations and attitudes. The response
rate, 12.91% (258/1998), may have increased the selection bias,
but it agrees with other similar studies. The response rate of
Web-based surveys is often low, and many strategies have been
investigated to increase it [29]. Finally, the heterogeneity of the
health care advocacy associations that participated could have
added further selection bias.
In conclusion, the survey shows that health apps and wearable
devices are sufficiently used and appreciated by patients as
potential supports for greater engagement in their health. There
are still obstacles to their use, however, on which developers
should work to make them more accessible and more useful.
The involvement of patients and their health care advocacy
associations in designing services and products based on these
technologies—and others—is desirable to overcome barriers
and make their development and acceptance easier and more
competitive.
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Porpora Trombotica Trombocitopenica Onlus, Associazione Onlus Carmine Speranza, Associazione Parkinson Rovigo & Amici
Onlus, Associazione Progetto Endometriosi, Associazione Reggiana per la Lotta e Cura dell’AIDS Onlus, Associazione Sarda
Paratetraplegici, Associazione Scientifica Culturale Alter Ego, Associazione Serena a Palermo Onlus, Associazione Traumi
Cranici Toscani ATRACTO Onlus, Associazione Vitadidonna Onlus, Associazione Vittorio Lodini progetto Seno, AVULSS
Associazione di Volontariato nelle Unità Locali dei Servizi Sociosanitari, Palermo, Cerignola per l’oncologia Onlus, CFS
Associazione Italiana Onlus, Cibo Amico allergia alimentare e anafilassi, CIDP Italia Onlus, CLEO Club Epatologi Ospedalieri,
Diabete Brescia Onlus Brescia e Provincia, Diabete Zero Onlus, Difendiamoci dal Diabete Cittanova, Donna Per Donna Onlus,
ESA Educazione alla Salute Attiva, Europa Donna Italia, Fand Ogliastra, Fand Milano, FAVO, Federasma e allergie, Federazione
Alzheimer Italia, Federazione Diabete Sicilia, Federazione Italiana Incontinenti e Disfunzioni del Pavimento Pelvico Fincopp,
Federazione Regionale Associazioni Toscane Diabetici Onlus, Fondazione Alessandra Bisceglia W Ale Onlus, Fondazione ANT
Italia Onlus, Fondazione Attilia Pofferi Onlus, GILS Gruppo Italiano per la Lotta alla Sclerodermia Onlus, Gruppo di discussione
e azione “Italia Glioblastoma Multiforme cancro al cervello”, GSD Non Vedenti Milano Onlus, INSU’ Associazione Giovani
Diabetici Onlus, Inversa Onlus, InVIta la vita Onlus, La Lampada di Aladino Onlus, Le Donne Scelgono, Lega Italiana per la
Lotta contro i Tumori Imperia Sanremo, Legaconsumatori Lucca, LIFC Piemonte Onlus, LILT Lega Italiana Per La Lotta Contro
I Tumori, LILT Lega Italiana Per La Lotta Contro I Tumori Forli’ Cesena, LILT Lega Italiana Per La Lotta Contro I Tumori
Ragusa, LILT Lega Italiana Per La Lotta Contro I Tumori Rimini, MEDeA Onlus, Pavia nel Cuore Onlus, Per Andare Oltre
Onlus, Plus Onlus, PRODES Progetto Diabete e Salute Fand Roma, Progetto Luna, Progetto Luna Onlus, Progetto Vita Onlus,
Salute Donna Onlus, SAMOT Onlus, Sardegna Medicina, Speranza Onlus Associazione Familiari Diversabili Psichici, Tarlov
Italia Onlus, UFHa unione famiglie handicappati, Unione Italiana Lotta alla Distrofia Muscolare Pisa,Verso Il Sereno Onlus,
Vivere senza stomaco si può, Voglia di Vivere Onlus, and WALCE Onlus.
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